STERIS plc
STEHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeSTERIS plc provides infection prevention products and services worldwide. At a $20.88B market cap, STERIS plc ranks as a large-cap company within healthcare. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences.
Market Cap
$20.88B
Beta
0.95
P/E (TTM)
26.83
P/E (Fwd)
17.58
EPS (TTM)
$7.93
EPS (Fwd)
$12.10
ROE
11.4%
ROA
6.6%
Cash
$439.6M
Total Debt
$1.93B
Free CF
$587.6M
52W Change
-12.1%
Annual Financials
Cash vs Debt
On the balance sheet, STE has $439.6M in cash with $1.93B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $587.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 11.4% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 6.6% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $4.22B (2022) to $5.46B (2025), reflecting a 29% increase over the period.
Investors considering STERIS plc should weigh the typical risks associated with STE's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence STERIS plc's trajectory.